Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-25 of 29 for your search:
Drug:
ABVD regimen
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Study of Radiotherapy With or Without Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) Versus ABVD Only in Patients With Stage I-IIA Hodgkin's Disease
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
16 and over
Sponsor:
Other
Protocol IDs:
CAN-NCIC-HD6
, E-JHD06, NCI-V94-0427, NCT00002561, HD6, JHD06
2.
Phase III Pilot Study of Alternating Courses of MOPP and ABDV plus Radiotherapy with or without Levamisole for Advanced Hodgkin's Disease
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
Protocol IDs:
MSKCC-75104
3.
Phase III Randomized Study of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) Versus Doxorubicin, Vinblastine, Vincristine, Bleomycin, Mechlorethamine, Etoposide, and Prednisone (Stanford V) With or Without Radiotherapy in Patients With Locally Extensive or Advanced Hodgkin's Lymphoma
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
16 and over
Sponsor:
NCI
Protocol IDs:
ECOG-2496
, CAN-NCIC-HD7, CALGB-59905, SWOG-E2496, E2496, NCT00003389, HD7
4.
Phase III Randomized Study of a Four-Drug Anthracycline-Based Regimen or a Seven-Drug Hybrid or Eight-Drug Alternating Regimen in Patients With Advanced Hodgkin's Disease
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
Not specified
Sponsor:
Protocol IDs:
MRC-UKLG-LY09
, EU-98020, NCT00003421
5.
Phase III Randomized Study of Epirubicin, Bleomycin, Vinblastine, and Prednisone (EBVP) Versus Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) Versus Cyclophosphamide, Doxorubicin, Vincristine, Bleomycin, Etoposide, Procarbazine, and Prednisone (BEACOPP), Followed By Involved-Field Radiotherapy (IF-RT) or No IF-RT in Patients With Hodgkin's Lymphoma
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
15 to 70
Sponsor:
Other
Protocol IDs:
EORTC-20982
, FRE-FNCLCC-98014, GELA-H9, NCT00005584
6.
Phase III Randomized Study of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine With or Without Autologous Peripheral Blood Stem Cell Transplantation and High-Dose Chemotherapy in Patients With Stage III or IV Hodgkin's Disease
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
15 to 65
Sponsor:
NCI
Protocol IDs:
SWOG-S9901
, CLB-59802, E-S9901, NCT00005090, S9901
7.
Phase III Randomized Study of Bleomycin, Doxorubicin, Etoposide, Mechlorethamine, Vinblastine, Vincristine, and Prednisone (Stanford V) Versus Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) in Patients With Previously Untreated Advanced Hodgkin's Lymphoma
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18 to 60
Sponsor:
Other
Protocol IDs:
BNLI-STANFORDV
, EU-20206, NCT00041210
8.
Phase III Extended vs Involved Field Radiotherapy with or without MOPP Chemotherapy for Childhood Hodgkin's Disease (Summary Last Modified 12/97 km)
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
under 18
Sponsor:
NCI
Protocol IDs:
CCG-541
, CLB-7691, POG-7660
9.
Phase III Radiotherapy plus MOPP (NM/VCR/PCB/PRED) and ABVD (ADR/BLEO/VBL/DTIC) for Stage I/II Hodgkin's Disease
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
MDA-RT-8001
10.
Phase III Study of MOPP (NM/VCR/PCB/PRED) vs ABVD (ADR/BLEO/VBL/DTIC) vs Alternating MOPP and ABVD for Stage III/IV Hodgkin's Disease and for Selected Patients with Stage I/II Disease
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
16 and over
Sponsor:
NCI
Protocol IDs:
CLB-8251
, CALGB-8251
11.
Phase III Radiotherapy Alone or in Combination with MOPP (NM/VCR/PCB/PRED) or MLMOPP (MOPP plus MTX/CF) for Hodgkin's Disease
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
UCCRC-2121B
, NCI-V83-0124
12.
Phase III MOPP (NM/VCR/PCB/PRED) plus Radiotherapy and ABVD (ADR/BLEO/VBL/DTIC), CVPP (CTX/VBL/PCB/PRED), or AB-DIC (ADR/BLEO/DTIC/CCNU/PRED) Salvage Therapy for Stage III Hodgkin's Disease in Adults
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Protocol IDs:
MDA-IM-8007
, NCI-V86-0049
13.
Phase III Radiotherapy plus MOPP (NM/VCR/PCB/PRED) vs ABVD (ADR/BLEO/VBL/DTIC) for Stage I/II Hodgkin's Disease with Unfavorable Prognosis
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
15 to 60
Sponsor:
Protocol IDs:
EORTC-20822
14.
Phase III Treatment of Newly Diagnosed and Recurrent Hodgkin's Disease
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
UCCRC-3954
, NCI-V84-0038
15.
Phase III Randomized Trial of Chemotherapy with MA/MA (MOPP-ABVD: NM/VCR/PCB/PRED-ADR/BLEO/VBL/DTIC) with vs without Adjuvant Radiotherapy in Patients with Advanced Hodgkin's Disease
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
any age
Sponsor:
NCI
Protocol IDs:
YALE-HIC-3281
, NCI-T85-0116D, T85-0116
16.
Phase III Randomized Comparison of Alternating Courses of MOPP (NM/VCR/PRED/PCB) and ABVD (ADR/BLEO/VBL/DTIC) vs ABVD plus Low-Dose Regional Radiotherapy in Children with Advanced Hodgkin's Disease (Summary Last Modified 02/89)
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
under 21
Sponsor:
NCI
Protocol IDs:
CCG-521
17.
Phase III Randomized Comparison of Combination Chemotherapy with MOPP/ABV Hybrid vs Sequential MOPP-ABVD in Adult Patients with Stages III and IV Hodgkin's Disease Previously Untreated with Chemotherapy (Summary Last Modified 02/89)
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
16 to 65
Sponsor:
NCI
Protocol IDs:
EST-4486
, CLB-8695, SWOG-8796, INT-0074
18.
Phase III Randomized Comparison of ABVD vs MOPP/ABV Hybrid in Adults with Advanced Hodgkin's Disease
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
over 15
Sponsor:
NCI
Protocol IDs:
CLB-8952
, CAN-NCIC-HD5, EST-5489, SWOG-8952, INT-0111, HD5
19.
Phase III Randomized, Prospective Study of ChlVPP (CLB/VBL/PCB/PRED) with vs without Radiotherapy for Patients with Responding Advanced Hodgkin's Disease (Summary Last Modified 10/97)
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
14 and over
Sponsor:
Other
Protocol IDs:
SAFR-CT-HD-2
20.
Phase III Study of G-CSF in the Mobilization of Peripheral Blood Mononuclear Cells (PBMC) and in Stimulating Engraftment of PBMC Following High-Dose Chemotherapy with BCNU/VP-16/CTX in Adult Patients with Relapsed Hodgkin's Disease (Summary Last Modified 11/91)
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
over 18 to 60
Sponsor:
NCI
Protocol IDs:
SUMC-26
, NCI-T90-0124O, T90-0124
21.
Phase III Randomized Comparison of Involved-Field vs Extended-Field Radiotherapy in Combination with ABVD (DOX/BLEO/VBL/DTIC) in Patients with Bulky Early-Stage Hodgkin's Disease (Summary Last Modified 05/92)
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
any age
Sponsor:
Protocol IDs:
MSKCC-91069
, NCI-V91-0178
22.
Phase II Study of Donor Leukocyte Infusions in Patients with Recurrent or Persistent Hematologic Malignancies After Allogeneic Bone Marrow Transplantation (Summary Last Modified 01/2000)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
65 and under
Sponsor:
NCI
Protocol IDs:
RPCI-RP-9807
, UTSMC-GVT-092-136, NCI-G98-1490
23.
Phase II Pilot Study of Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone, Filgrastim (G-CSF), Dacarbazine, Vinblastine, and Radiotherapy in Pediatric Patients With Previously Untreated Stage II, III, or IV Hodgkin's Disease
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
21 and under
Sponsor:
NCI
Protocol IDs:
COG-59704
, NCT00004010, CCG-59704
24.
Phase II Pilot Chemotherapy with ABVD (ADR/BLEO/VBL/DTIC) Followed by Low-Dose Radiotherapy in Children with Stage IV Hodgkin's Disease
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
under 21
Sponsor:
NCI
Protocol IDs:
CCG-521P
25.
Phase II Study of Chemotherapy with CBV (CPA/BCNU/VP-16) Followed by Autologous Bone Marrow Transplant for Patients with Resistant Hodgkin's Disease (Summary Last Modified 11/88)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
16 and over
Sponsor:
NCI
Protocol IDs:
CLB-8783
, CALGB-8783
Select All on Page
1
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
